Loading article…
Eli Lilly buys Merida Biosciences for $2.875 billion as S&P 500 stocks fall. Markets react to rising oil prices and hawkish Fed signals from Kevin Warsh.
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion in cash, marking the drugmaker's latest effort to deploy capital from its obesity-drug windfall into new therapeutic areas [3]. The deal coincides with a broader market retreat as rising geopolitical tensions and hawkish Federal Reserve rhetoric push the 10-year Treasury yield to 4.75% [3].
| At a glance | |
|---|---|
| Merida Biosciences Deal | $2.875 Billion |
| 10-Year Treasury Yield | 4.75% |
| WTI Crude Oil | >$85 per barrel |
| GE Vernova Stock Move | -2% |
Stocks traded lower to start the week as energy prices surged following an exchange of strikes between the U.S. and Iran over the weekend [3]. WTI crude climbed back above $85 a barrel, while international benchmark Brent crude rose above $90 [3]. These energy gains, paired with a hawkish speech from Federal Reserve Chairman Kevin Warsh at Jackson Hole, pressured broader equity indices [3]. Communication services led the market decline, while technology was the only S&P 500 sector to trade in positive territory during afternoon hours [3].
The acquisition of Merida Biosciences targets a new class of biologics designed to degrade pathogenic autoantibodies, a departure from traditional immunosuppressive treatments [3]. CEO David Ricks stated that the company has completed more deals in 2026 than in all of 2025, utilizing cash flow generated by its obesity drug portfolio [3]. While some employers have recently dropped coverage for GLP-1 medications due to cost concerns, Ricks characterized the net impact on demand as "flat," arguing that treating obesity remains a more cost-effective long-term strategy for employers than managing the resulting health complications [3].
GE Vernova shares fell 2% on Monday following social media remarks from Elon Musk regarding SpaceX’s internal development of natural gas turbine blades [3]. Musk claimed that in-house casting could accelerate the production of power-generating equipment by up to 18 months [3]. Howmet Aerospace, which manufactures turbine blades, also saw its shares decline following the post [3]. Analysts at Jefferies noted that it could take at least four years for SpaceX to industrialize such a facility and navigate customer negotiations, suggesting that GE Vernova’s pricing power may remain intact in the near term [3].
The market remains focused on whether the current bottleneck in power-generating equipment will persist, as analysts monitor potential political pushbacks that could delay data center projects ahead of the midterm elections [3]. Meanwhile, Lilly’s aggressive M&A pace signals a continued effort to diversify its pipeline beyond its current obesity-focused revenue base [3].
Coverage is mostly measured — 268 of 290 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 4 outlets · Sep 7, 2026 · How we report
The S P 500 is a stock market index that tracks the performance of 500 large-capitalization companies listed on United States stock exchanges. It is maintained by S&P Dow Jones Indices and serves as a benchmark representing approximately 83% of the total market capitalization of U.S. public companies.
Companies are selected for the S P 500 by a committee based on specific criteria established for the S&P 1500 index. These criteria determine which large-capitalization stocks are included in the index.
Information Technology is the largest sector in the S P 500, comprising 37.4% of the index. Other significant sectors include Financials at 12.2% and Communication Services at 9.67%.
Investors can access products linked to the S P 500, such as index funds, exchange-traded funds, mutual funds, and derivatives like options and futures. These products are designed to replicate the performance of the S P 500 or provide modified risk/return profiles.